EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Complex Contributions of Methylglyoxal to Pain, Axon Degeneration, and Diabetic Peripheral Neuropathy

Gentry Totta-Griese iD, Douglas E Wright

Journal of Neurochemistry · 2026

DOI: 10.1111/jnc.70529 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Neurochemistry, 2026. Verfasst von Gentry Totta-Griese und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The University of Kansas Medical Center, Kansas, Kansas, USA. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Pyruvaldehyde, Axons, Nerve Degeneration. Die Arbeit nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Kansas INBRE, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methylglyoxal is a highly reactive by‐product of glycolysis that is elevated in diabetes and contributes to the development of diabetic peripheral neuropathy (DPN). DPN is characterized by nerve degeneration, typically manifesting in patients' extremities. This leads to patients experiencing numbness, burning, and pain. It has been established that elevated methylglyoxal levels lead to nociception, but the broader cellular effects of methylglyoxal on neurons in the dorsal root ganglia (DRG) remain poorly understood. This review provides mechanistic insight regarding methylglyoxal's impact on various cell types and disease contexts. Five main mechanisms were identified: protein glycation, proteostasis change, oxidative stress, metabolic changes, and increased inflammation. These mechanisms are thoroughly interconnected, contributing to cellular dysfunction associated with DPN. We propose that methylglyoxal functions as a central mediator in cellular stress, linking hyperglycemia and elevated glycolysis to neuronal dysfunction in DPN. There is extensive evidence that these mechanisms are methylglyoxal‐driven in other cell types and diseases, but a gap in the field remains in determining whether and how they occur in DRG neurons. This is particularly important, as DPN is a frequent comorbidity in diabetes and metabolic diseases and greatly affects patients' quality of life. Understanding the effect of methylglyoxal on DRG in relation to these mechanisms will provide novel insights into the development of DPN and lead to new therapeutic targets. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NeuropathiesPyruvaldehydeAxonsNerve DegenerationPainHumansAnimalsGanglia, SpinalOxidative Stress

Substanzen

Pyruvaldehyde

Autor:innen und Institutionen

  • Department of Anesthesiology, The University of Kansas Medical Center, Kansas, Kansas, USA.

ORCID-Profile: Gentry Totta-Griese

Förderung

  • NIH HHS
  • Kansas INBRE
  • NINDS NIH HHS
  • National Institutes of Health
  • Kansas IDeA Network of Biomedical Research Excellence

Zitieren

APA

Totta-Griese, G., & Wright, D. E. (2026). Complex Contributions of Methylglyoxal to Pain, Axon Degeneration, and Diabetic Peripheral Neuropathy. Journal of Neurochemistry. https://doi.org/10.1111/jnc.70529

Vancouver

Totta-Griese G, Wright DE. Complex Contributions of Methylglyoxal to Pain, Axon Degeneration, and Diabetic Peripheral Neuropathy. Journal of Neurochemistry. 2026. doi:10.1111/jnc.70529

BibTeX
@article{TottaGriese2026,
  author = {Totta-Griese, Gentry and Wright, Douglas E},
  title = {Complex Contributions of Methylglyoxal to Pain, Axon Degeneration, and Diabetic Peripheral Neuropathy},
  journal = {Journal of Neurochemistry},
  year = {2026},
  doi = {10.1111/jnc.70529}
}
Kostenlos starten →